Weighing Shortage Risk, FDA Clears Releasing Metabolic Formulas Made At Abbott’s Closed Plant

With Michigan facility closed as cause of bacterial contamination is investigated, FDA announces “has no objection” to Abbott releasing specialty and metabolic formulas “to individuals needing urgent, life-sustaining supplies” on a case-by-case basis.

• Source: Alamy

Abbott Laboratories Ltd is releasing, at the US Food and Drug Administration’s request, limited quantities of metabolic infant nutrition formulas distributed through medical referrals which were made at a facility it closed earlier in 2022 after recalling contaminated formula brands available in stores.

While the Sturgis, MI, facility remains closed as the cause of the bacterial contamination is investigated, the agency announced on...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Regulation

More from Policy & Regulation